Canabo wholly owns and operates Cannabinoid Medical Clinic (CMC), Canada’s largest referral-only clinic for medical cannabis. After opening in 2014, Canabo now has ten locations including Toronto, Barrie, Ottawa, Hamilton, Halifax, St. John’s and Edmonton, with a number of additional clinics opening in Alberta, New Brunswick and Ontario in 2016.
CMC has over 40 physicians working in our clinics. We are a physician referral-only medical clinic. We work closely with both patients and physicians to address the need for cannabinoid therapy. The majority of our patients visit us for symptoms related to chronic pain, cancer, epilepsy, arthritis, anxiety, and MS. These patients have often tried multiple first and second line therapies with variable success, and have ongoing symptoms that cause significant distress and functional burden.
Our emphasis at CMC is on maximizing patient function. We view medical cannabinoids as one potential component of a patient’s treatment plan, and screen each patient for suitability. If a patient is a candidate for cannabinoid therapy, they will then meet with our Clinical Educator, who will work with them to navigate the process of selecting and registering with one of the many Licensed Producers as well as identifying strains that may suit their needs. Patient consults are covered by the Provincial health plan, providing a free service to the patient. Additionally, CMC is collecting the largest known source of data relating to Medical Marijuana in the industry.
CMC does not accept patients that access their medical marijuana via illegal dispensaries or home grown sources. All clinics are staffed with physicians and provide telemedicine for remote rural service and recheck appointments on stable patients. CMC does not accept walk-in patients and is very much focused on providing the highest standard of Medical Marijuana care.
Canabo’s business model creates revenue from three primary areas: clinic operation, subscription access to our Medical Marijuana patient database, and consulting services to insurance companies and employers relating to use of Medical Marijuana.